The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes.
Brad Swanson
Advertisement
Articles by Brad Swanson
Advertisement
Latest Updated Articles
Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity TestingPublished: March 1st 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
